| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/08/2004 | EP1454634A1 Preparation compositions containing acid-unstable physiologically acitve compounds and process for producing the same |
| 09/08/2004 | EP1454631A1 Oral insulin composition and methods of making and using thereof |
| 09/08/2004 | EP1454630A1 Long acting injectable insulin composition and methods of making and using thereof |
| 09/08/2004 | EP1454624A1 Antiviral, antibacterial pharmaceutical composition of cantharidic anhydride and method of preparation thereof |
| 09/08/2004 | EP1453963A2 A structure for presenting desired peptide sequences |
| 09/08/2004 | EP1453916A2 Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |
| 09/08/2004 | EP1453909A1 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 09/08/2004 | EP1453859A2 Chemically-modified human growth hormone conjugates |
| 09/08/2004 | EP1453855A1 Antimicrobial bolisin peptides |
| 09/08/2004 | EP1453845A2 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same |
| 09/08/2004 | EP1453841A1 Technetium or rhenium complexes, radiopharmaceutical products comprising them |
| 09/08/2004 | EP1453837A2 Targeted therapeutics and uses thereof |
| 09/08/2004 | EP1453816A2 Phenoxy amine compounds and compositions for delivering active agents |
| 09/08/2004 | EP1453598A1 Method for preparing a multiple water/oil/water emulsion |
| 09/08/2004 | EP1453546A2 Treatment of angiogenesis disorders using targeted nanoparticles |
| 09/08/2004 | EP1453545A1 Water-soluble polymer conjugates of retinoic acid |
| 09/08/2004 | EP1453544A2 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 09/08/2004 | EP1453542A1 Nutraceutical composition |
| 09/08/2004 | EP1453537A1 Composition for viral preservation |
| 09/08/2004 | EP1453536A1 Composition for the preservation of viruses |
| 09/08/2004 | EP1453525A1 Selective targeting of apoptotic cells |
| 09/08/2004 | EP1453523A1 Heparin-containing ophthalmic agent |
| 09/08/2004 | EP1453519A2 Aqueous ifosfamide composition |
| 09/08/2004 | EP1453517A1 Platinum derivative pharmaceutical formulations |
| 09/08/2004 | EP1453508A1 Tempamine compositions and use against cellular oxidative damage |
| 09/08/2004 | EP1453502A2 Pharmaceutical formulations comprising indolinone derivatives |
| 09/08/2004 | EP1453489A2 Acetaminophen compositions |
| 09/08/2004 | EP1453487A1 Pharmaceutical dosage form with multiple coatings |
| 09/08/2004 | EP1453485A2 Matrices for stabilizing and controlled release of problematic substances |
| 09/08/2004 | EP1453483A2 High-concentration lidocaine compositions and methods for their preparation |
| 09/08/2004 | EP1453481A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
| 09/08/2004 | EP1453447A1 Composition and transdermal drug delivery device |
| 09/08/2004 | EP1453446A1 Nitric oxide releasing eptfe coated medical device sandwich |
| 09/08/2004 | EP1347744B1 Solid dispersions of nitrate active principles |
| 09/08/2004 | EP1326624B1 Method for producing phyllanthus extracts |
| 09/08/2004 | EP1292281B1 Novel tiotropium-containing inhalation powder |
| 09/08/2004 | EP1225897B1 Composition for treatment of constipation and irritable bowel syndrome |
| 09/08/2004 | EP1189579B1 Gelled aqueous cosmetic compositions |
| 09/08/2004 | EP1077669B1 Cosmetic product |
| 09/08/2004 | EP1075281B1 Polyol-ifn-beta conjugates |
| 09/08/2004 | EP1039874B1 Compositions and methods for treatment of alopecia |
| 09/08/2004 | EP1014954B9 Transdermal therapeutic system |
| 09/08/2004 | EP0975370B9 Composition and method for enhancing transport across biological membranes |
| 09/08/2004 | EP0758232B1 Methods for modulating t cell responses by manipulating intracellular signal transduction |
| 09/08/2004 | CN1527839A Modified human brain-derived neutrophic factor (BDNF) with reduced immunogenicity |
| 09/08/2004 | CN1527729A Topical pharmaceutical formulation |
| 09/08/2004 | CN1527727A Improved chelator conjugates |
| 09/08/2004 | CN1527726A Conjugates of erythropoietin (PEP) with polyethylene glycol (PEG) |
| 09/08/2004 | CN1527724A Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan |
| 09/08/2004 | CN1527716A Anti-virus agent |
| 09/08/2004 | CN1527714A Pharmaceutical composition and method for treating hypogonadism |
| 09/08/2004 | CN1527706A Pharmaceutical compositions containing terbinafin and use thereof |
| 09/08/2004 | CN1527705A Pharma ceutical formulation containing and LTB4 antagonist |
| 09/08/2004 | CN1527701A Tablets quickly disintegrated in oral cavity |
| 09/08/2004 | CN1527700A Compaction process for manufacture of sodium phenytoin dosage form |
| 09/08/2004 | CN1527699A Stable injecta composition and method |
| 09/08/2004 | CN1527698A 控释可生物降解的凝胶基质 Controlled release biodegradable gel matrix |
| 09/08/2004 | CN1527697A Immune modulation device for use in animals |
| 09/08/2004 | CN1527689A Insert for the treatment of dry eye |
| 09/08/2004 | CN1527670A Aimal growth regulating composition and its prepn and use |
| 09/08/2004 | CN1526723A Cholesterin derivative containing azobenzol group and its synthesis and use |
| 09/08/2004 | CN1526449A Method of eliminating and inhibiting bitter of medicine |
| 09/08/2004 | CN1526391A Composition containing 5-[4-[2-(N-methyl-N-2-pyridyl)amino oxethyl] benzyl] thiazolidine-2, 4-diketone |
| 09/08/2004 | CN1165345C Prucalopride oral solution and preparing method thereof |
| 09/08/2004 | CN1165341C Liquid gonadotropin containing formulations |
| 09/08/2004 | CN1165340C Cartilage/bone inducing materials for reparation |
| 09/08/2004 | CN1165339C Pharmaceutical compositions of erythropoietin |
| 09/08/2004 | CN1165315C Remedies for joint diseases |
| 09/08/2004 | CN1165309C Stable compositions comprising levosimendan and alginic acid |
| 09/08/2004 | CN1165307C Controlled release oxycodone compositions |
| 09/08/2004 | CN1165300C Parenteral paclitaxel stable non-toxic formulation |
| 09/08/2004 | CN1165297C Composition for transdermal administration |
| 09/08/2004 | CN1165296C Application of water-soluble or water-dispersible polymerizates which contain poly-ether and which are used as coating agent, binding agent and/or film-forming auxiliary agent |
| 09/08/2004 | CN1165293C New oral formulation for 5-HT4 agonists or antagonists |
| 09/08/2004 | CN1165291C Anti-fungus composition with improved biological utilization rate |
| 09/08/2004 | CN1165290C New medicine release system-liposolubility medicinal preparation |
| 09/08/2004 | CN1165289C Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system |
| 09/07/2004 | US6787638 Tumor specific human monoclonal antibodies and methods of use |
| 09/07/2004 | US6787636 Modified serum albumin with reduced affinity for nickel and copper |
| 09/07/2004 | US6787572 Use of ubiquinone Q10 for the local treatment and prevention of post-surgical ophthalmologic pathologies |
| 09/07/2004 | US6787532 Formulation containing anti-inflammatory androstane derivatives |
| 09/07/2004 | US6787529 Synergistic mixture of vitamin d and corticosteroids; skin disorders |
| 09/07/2004 | US6787517 Agent and methods for treating pain |
| 09/07/2004 | US6787342 Paste formulations |
| 09/07/2004 | US6787335 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 09/07/2004 | US6787160 Compositions and methods for high sorption of skin materials and delivery of sulfur |
| 09/07/2004 | US6787156 Controlled release composition |
| 09/07/2004 | US6787154 Artificial antigen presenting cells |
| 09/07/2004 | US6787153 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
| 09/07/2004 | US6787152 Balancing the molecular properties (van der waals forces and dipole moments) of all the components against those of all the components plus the particular active agent. |
| 09/07/2004 | US6787149 Topical application of opioid analgesic drugs such as morphine |
| 09/07/2004 | CA2337015C Excipient |
| 09/07/2004 | CA2102777C Novel compositions based on taxane class derivatives |
| 09/05/2004 | CA2428711A1 Formulations and methods of delivery of intact tocopheryl succinate to humans |
| 09/03/2004 | CA2456410A1 Stabilised pharmaceutical composition comprising an extented release non-steroidal anti-inflammatory agent and an immediate release prostaglandin |
| 09/02/2004 | WO2004074509A2 Reversible attachment of a membrane active polymer to a polynucleotide |
| 09/02/2004 | WO2004074437A2 Compositions and methods for cancer immunotherapy |
| 09/02/2004 | WO2004074434A2 Methods and compositions for administering therapeutic and diagnostic agents |
| 09/02/2004 | WO2004074345A2 Carbonate esters of polyethylene glycol activated by means of oxalate esters |
| 09/02/2004 | WO2004074171A1 Method for introducing functional material into organic nanotube |